229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.99%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-9.56%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-71.19%
Negative EBIT growth while VUZI is at 11.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-71.19%
Negative operating income growth while VUZI is at 10.47%. Joel Greenblatt would press for urgent turnaround measures.
27.32%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
26.73%
EPS growth above 1.5x VUZI's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
23.91%
Diluted EPS growth above 1.5x VUZI's 9.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.70%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.00%
Diluted share count expanding well above VUZI's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-83.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-89.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
12.91%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-44.54%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.90%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-84.28%
Negative 10Y OCF/share CAGR while VUZI stands at 60.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
668.87%
5Y OCF/share CAGR above 1.5x VUZI's 51.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-56.65%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
38.15%
Net income/share CAGR 1.25-1.5x VUZI's 33.50%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
141.38%
5Y net income/share CAGR above 1.5x VUZI's 14.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
117.87%
3Y net income/share CAGR above 1.5x VUZI's 36.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
112.38%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
17.45%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
162.86%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while VUZI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
5.38%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-33.33%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-7.63%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.18%
We have a declining book value while VUZI shows 2.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
2.22%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-10.03%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
